News

Use of drug eluting stents increases in the US but only for some groups

BMJ 2004; 329 doi: http://dx.doi.org/10.1136/bmj.329.7476.1205-c (Published 18 November 2004) Cite this as: BMJ 2004;329:1205
  1. Janice Hopkins Tanne
  1. New York

    In the nine months after the first drug eluting stent was approved in the United States, the new style stent was used in 35% of all angioplasties. Stents—metal scaffold tubes that support arteries after balloon angioplasty—can be coated in a slow release drug to reduce restenosis, in which the artery becomes blocked again.


    Embedded Image

    The sirolimus-eluting Cypher stent, the first to be approved in the US, was used in 35% of angioplasties in the nine months after its approval

    Credit: CORDIS CORPORATION

    Use of drug eluting stents rose rapidly, from 20% in the first quarter after its …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe